HNF1B and diabetes mellitus: Genomics suggests that DM individuals with the HNF1B gene variants (i.e., monogenic diabetes type 5/maturity-onset diabetes of the young type 5 (MODY5)) are more protected from PCa, so this would subsequently hinder any tumor-related growth factors [22].